Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL
- PMID: 29872562
- PMCID: PMC5980379
- DOI: 10.1080/2162402X.2018.1432328
Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL
Erratum in
-
Correction.Oncoimmunology. 2022 Nov 18;11(1):2145651. doi: 10.1080/2162402X.2022.2145651. eCollection 2022. Oncoimmunology. 2022. PMID: 36419824 Free PMC article.
Abstract
Analysis of the T cell receptor (TR) repertoire of chronic lymphocytic leukemia-like monoclonal B cell lymphocytosis (CLL-like MBL) and early stage CLL is relevant for understanding the dynamic interaction of expanded B cell clones with bystander T cells. Here we profiled the T cell receptor β chain (TRB) repertoire of the CD4+ and CD8+ T cell fractions from 16 CLL-like MBL and 13 untreated, Binet stage A/Rai stage 0 CLL patients using subcloning analysis followed by Sanger sequencing. The T cell subpopulations of both MBL and early stage CLL harbored restricted TRB gene repertoire, with CD4+ T cell clonal expansions whose frequency followed the numerical increase of clonal B cells. Longitudinal analysis in MBL cases revealed clonal persistence, alluding to persistent antigen stimulation. In addition, the identification of shared clonotypes among different MBL/early stage CLL cases pointed towards selection of the T cell clones by common antigenic elements. T cell clonotypes previously described in viral infections and immune disorders were also detected. Altogether, our findings evidence that antigen-mediated TR restriction occurs early in clonal evolution leading to CLL and may further increase together with B cell clonal expansion, possibly suggesting that the T cell selecting antigens are tumor-related.
Keywords: T cell receptor (TR); antigen restriction; chronic lymphocytic leukemia (CLL); clonotype; monoclonal B cell lymphocytosis (MBL).
Figures



Similar articles
-
Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia.PLoS One. 2013 Jul 3;8(7):e67751. doi: 10.1371/journal.pone.0067751. Print 2013. PLoS One. 2013. PMID: 23844084 Free PMC article.
-
Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia.Exp Hematol. 2021 Mar;95:68-80. doi: 10.1016/j.exphem.2020.12.007. Epub 2021 Jan 7. Exp Hematol. 2021. PMID: 33421548 Free PMC article.
-
Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation.Leukemia. 2016 May;30(5):1055-61. doi: 10.1038/leu.2015.351. Epub 2015 Dec 21. Leukemia. 2016. PMID: 26686246
-
What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.Semin Oncol. 2016 Apr;43(2):201-8. doi: 10.1053/j.seminoncol.2016.02.013. Epub 2016 Feb 6. Semin Oncol. 2016. PMID: 27040697 Review.
-
CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it?Semin Cancer Biol. 2010 Dec;20(6):384-90. doi: 10.1016/j.semcancer.2010.08.005. Epub 2010 Sep 15. Semin Cancer Biol. 2010. PMID: 20816789 Review.
Cited by
-
Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic Leukemia.Hemasphere. 2021 Apr 26;5(5):e564. doi: 10.1097/HS9.0000000000000564. eCollection 2021 May. Hemasphere. 2021. PMID: 33912812 Free PMC article.
-
Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues.Leukemia. 2019 Mar;33(3):625-637. doi: 10.1038/s41375-018-0250-6. Epub 2018 Sep 28. Leukemia. 2019. PMID: 30267008
-
Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect.Exp Hematol Oncol. 2022 Sep 22;11(1):60. doi: 10.1186/s40164-022-00315-9. Exp Hematol Oncol. 2022. PMID: 36138486 Free PMC article. Review.
-
Normal Residual Lymphoid Cell Populations in Blood as Surrogate Biomarker of the Leukemia Cell Kinetics in CLL BinetA/Rai 0.Cancers (Basel). 2025 Jan 21;17(3):347. doi: 10.3390/cancers17030347. Cancers (Basel). 2025. PMID: 39941719 Free PMC article.
-
Monoclonal B-Cell Lymphocytosis: The Silent Clone the Haematologists Should Not Neglect.Hematol Oncol. 2025 Jun;43 Suppl 2(Suppl 2):e70084. doi: 10.1002/hon.70084. Hematol Oncol. 2025. PMID: 40517439 Free PMC article. Review.
References
-
- Vardi A, Dagklis A, Scarfò L, Jelinek D, Newton D, Bennett F, Almeida J, Rodriguez-Caballero A, Allgood S, Lanasa M, et al. Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL. Blood. 2013;121:4521–8. doi:10.1182/blood-2012-12-471698. PMID:23596047. - DOI - PubMed
-
- Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, Schulman P, Vinciguerra VP, Rai K, Rassenti LZ, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102:1515–25. doi:10.1172/JCI3009. PMID:9788964. - DOI - PMC - PubMed
-
- Agathangelidis A, Darzentas N, Hadzidimitriou A, Brochet X, Murray F, Yan XJ, Davis Z, van Gastel-Mol EJ, Tresoldi C, Chu CC, et al. Stereotyped B cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood. 2012;119:4467–75. doi:10.1182/blood-2011-11-393694. PMID:22415752. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous